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A compelling association has been observed between cardiovascular disease (CVD) and depression, suggesting individuals
withdepressiontobe at signiﬁcantlyhigherrisk for CVD and CVD-related mortality. Systemicimmune activation, hypothalamic–
pituitary–adrenal (HPA) axis hyperactivity, arterial stiffness and endothelial dysfunction have been frequently implicated in this
relationship. Although a differential epidemiological association between CVD and depression subtypes is evident, it has not
been determined if this indicates subtype speciﬁc biological mechanisms. A comprehensive systematic literature search was
conducted using PubMed and PsycINFO databases yielding 147 articles for this review. A complex pattern of systemic immune
activation, endothelial dysfunction and HPA axis hyperactivity is suggestive of the biological relationship between CVD and
depression subtypes. The ﬁndings of this review suggest that diagnostic subtypes rather than a unifying model of depression
should be considered when investigating the bidirectional biological relationship between CVD and depression. The suggested
model of a subtype-speciﬁc biological relationship between depression and CVDs has implications for future research and
possibly for diagnostic and therapeutic processes.
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Introduction
The association between cardiovascular disease (CVD) and
depression is well established and is suggested to be
bidirectional. Numerous clinical and epidemiological studies
investigating the association of depression and CVD have
suggestedthatdepressionindependentlyincreasestheriskof
CVD 1.5-fold on average, and that patients with coronary
artery disease and depression have a two- to threefold
increased risk of future non-fatal and fatal cardiac events
compared with those cardiac patients without depression.
1–4
Biological mechanisms that might link these two conditions
together include the hypothalamic–pituitary–adrenal (HPA)
axis, pro-inﬂammatory cytokines, changes of arterial elasticity
and endothelial function (for reviews see refs 1,4–14).
Many epidemiological and clinical studies examining
biological models of the relationship between CVD and
depression have classiﬁed depression dichotomously either
as yes/no or restricted analyses to major depression (MD)
only. However, more recent research has begun to differ-
entiate depressive subtypes such as dysthymia, melancholic
MD (MMD), MD with typical or atypical features (see
description of subtypes in Diagnostic and Statistical Manual
of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-
TR); American Psychiatric Association
15). Although differ-
ences in the strength of the association between various
depression subtypes and CVD have been demonstrated,
16–27
it remains unclear if these subtype-speciﬁc associations are
caused by a subtype-speciﬁc biological mechanism. Surpris-
ingly, studies directly addressing this question are lacking. If
this assumption would be true one would expect ﬁrstly that
subtypes of depression are characterized by speciﬁc biologi-
cal models and secondly that these speciﬁc models are also
relevant for the pathogenesis of CVD.
The aim of this review is to identify biological models
and correlates of subtypes of depression that might be
involved in the relationship with CVD. This review proposes
a differential subtype model of depression relevant for the
association with CVD as opposed to a unifying model of
depressionthatiscommonlyusedintheliteratureonCVDand
depression comorbidity.
The literature search for this review was carried out
according to the PRISMA (preferred reporting items for
systematic reviews and meta-analyses) guidelines as they
apply to systematic reviews.
28 A systematic literature search
was performed using the PubMed and PsycINFO databases
covering articles from 1969–2011. The following search terms
were used: (dysthymi* or (subsyndromal and depression) or
(minor and depression) or (subthreshold and depression)) or
bipolar disorder (BD) or MD or melanchol* or (depressi* and
(melanchol* or atypical or psycho* or vascular)) and (immune
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www.nature.com/tpor inﬂamm* or cytokine or glucocorticoid or cortisol or
hypothalamus or endothelium or coag* or clotting or thrombo-
sis). A second search was conducted as above, but with the
addition of the following: and (CVD or stroke or ischemic heart
disease or myocardial infarction or coronary heart disease or
arterialstiffnessoratherosclerosis).Articleswerealsoobtained
by reviewing reference lists of review and research articles.
A total of 736 studies were found using these search terms.
A total of 371 articles remained after assessment of abstracts
for relevance to the aims of this review. Of these, 224 studies
were excluded after review of the full text if they did not directly
comparebetween subtypesofdepression,did notprovide data
for individual subtypes, included child/adolescent populations
ordidnotincludemeasurementofrelevantbiomarkers.Inmost
cases cross-sectional studies were also excluded; however,
where studies of a longitudinal design were not available then
cross-sectional studies were retained. In all, 147 studies were
included in the ﬁnal review (Figure 1).
The bidirectional relationship between depression
and CVD
The relationship between depression and CVD has been
proposed to be bidirectional; existing depression increases
the risk of incident CVD and a history of CVD increases the
risk of depression. Many prospective and retrospective
studies have investigated the association of existing depres-
sion and incident CVD.
29–39 Several meta-analyses of these
studies have demonstrated a signiﬁcant positive correlation
with a moderate effect size of 1.5–2.7.
3,40–42
Similarly, several studies have investigated the role of
depression status as a prognostic factor in patients with
existing CVD.
43–50 Meta-analysis of these studies suggests
that depressed patients have a 1.6–2.7-fold increased risk for
further cardiovascular events within 24 months.
42,51–53 Con-
versely, relatively few studies have investigated the role of
existing CVD in increasing the risk for the onset of depression
(Supplementary Table).
39,43,54 To our knowledge, this data
has not been subjected to meta-analysis.
Analysis of the association between CVD and subtypes
of depression reveals that the relationship with CVD
appears to be particularly strong in patients with dysthymic
disorder,
16,18,19,23 and BDs.
16,17,22,27 However, this literature
is signiﬁcantly limited by the paucity of prospective studies
and studies that investigate a larger range of subtypes of
depression (Table 1).
In addition to its association with CVD, depression is also
signiﬁcantly associated with several other major cardiac risk
factors including smoking, obesity and diabetes.
55,56 Many
studies, however, have demonstrated that depression re-
mains independently associated with CVD even after adjust-
ing for these risk factors. This suggests that there are other
mediators of this relationship including both biological and
behavioral mediators.
2,55
Biological mechanisms involved in the CVD-depression
association
The relationship between depression and CVD has been
proposed to be bidirectional; that is, existing depression
increases the risk of incident CVD and a history of CVD
increases the risk of depression. Many prospective and
retrospective studies have investigated the association of
existing depression and incident CVD.
29–39 Several meta-
analyses of these studies have demonstrated a signiﬁcant
positivecorrelationwithamoderateeffectsizeof1.5–2.7.
3,40–42
Similarly, several studies have investigated the role of depres-
sion status as a prognostic factor in patients with existing
CVD.
43–50 Meta-analysis of these studies suggests that
depressed patients have a 1.6–2.7-fold increased risk for
further cardiovascular events within 24 months.
42,51–53 Con-
versely, relatively few studies have investigated the role of





patients with dysthymic disorder,
16,18,19,23 and BDs.
16,17,22,27
However, this literature is signiﬁcantly limited by the paucity of
prospective studies and by studies that investigate a larger
range of subtypes of depression.
In addition to its association with CVD, depression is also
signiﬁcantly associated with several major cardiovascular risk
factors, including smoking, obesity and diabetes.
55 Many
studies, however, have demonstrated that depression re-
mains independently associated with CVD even after adjust-
ing for these risk factors. This suggests that there are other
factors impactingonthis relationship, including both biological
and behavioral mediators
2,55 (Figure 2).
Studies investigating immune system functioning in indivi-
duals with ‘depression’, irrespective of depressive subtypes,
have found that many of these individuals manifest elevated
inﬂammatory markers, particularly c-reactive protein (CRP),
interleukin-6 (IL-6), interleukin-1b (IL-1b) and tumor necrosis
factor-a (TNF-a).
57,58 Several authors have suggested that
this association of depression and inﬂammatory markers may
be a key biological link in the comorbidity of depression and
CVD (see for reviews refs 1,4,7,10,12,13,59). This may be
mediated by interactions of inﬂammatory signaling cascades
with several key processes implicated in the pathogenesis
and pathophysiology of CVD. Key among these processes is
atherosclerosis. It has been proposed that inﬂammatory
mediators may accelerate the progression of atherosclerosis





736 articles were identified
and 365 were excluded after
a review of the body and/or
abstracts
224 articles were excluded





Figure 1 Study inclusion ﬂowchart.
Biology of depression-heart disease comorbidity































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Biology of depression-heart disease comorbidity
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3
Translational Psychiatryleukocytes to atherosclerotic lesions, inducing endothelial
activation and expression of adhesion molecules and stimu-
lating the expression of vascular endothelial growth factors
(see for review ref. 60). Furthermore, inﬂammatory signaling
cascades may amplify and accelerate the process of
coagulation and thrombus formation.
61
It has been suggested that the dysfunction of the HPA axis
may also contribute to the pathogenesis of depression
and comorbid CVD.
1,7 This contribution may be mediated, at
least in part, by the loss of glucocorticoid receptor-mediated
negative feedback on inﬂammatory signaling. It is also worth
noting that the disruptions of the HPA axis may be reciprocally
regulatedbyalteredexpressionofpro-inﬂammatorycytokines
constituting a complex bidirectional biological crosstalk.
62
Dysregulation of the HPA axis may also lead to sympatho-
adrenal hyperactivity via central pathways. This hyperactivity
may lead to an increase in vasoconstrictive tone, heart rate
and platelet activation each of which have been implicated in
the progression to CVD.
7,63 Furthermore, excesssympathetic
drive may result in reduced heart rate variability, which may
increase vulnerability to arrhythmia.
64
Endothelial dysfunction is a recognized risk factor for CVD
that is also often observed in patients with depression.
65–68 In
both ‘healthy’ young volunteers and patients with CVD,
depression status was associated with attenuated arterial
dilatory responses to ﬂow and nitroglycerin in addition to an
increased expression of endothelial adhesion molecules and
chemokines.
69,70 These factors may function to predispose
these patients to atherosclerosis, thrombosis and vasos-
pasm.
Biological mechanisms in depression subtypes relevant
to CVD-depression comorbidity
More recent research has begun to investigate immune
activation among depressed patients according to depression
subtype,whichmighthelptoimprovetheunderstandingofthe
biological mechanisms underlying the relationship between
CVD and depression.
MMD. Much research over the last decades has investigated
whether the subtype of MMD may have a separate
underlying pathophysiology to other non-melancholic forms
of MD (NMMD) (Table 2a). Particularly relevant to CVDs are
the investigation of immune alterations in MMD.
Many studies have investigated the proﬁle of pro-inﬂam-
matory cytokines expressed in MMD as compared with
NMMD; however, no consistent pattern has emerged. Of the
pro-inﬂammatory cytokines IL-1b has been the most fre-
quently investigated. Studies of serum IL-1b have variously
reported increased,
71 decreased
72 or non-signiﬁcantly differ-
ent
73,74 levels in MMD relative to NMMD. Similarly, study
of ex-vivo lipopolysaccharide stimulated whole blood IL-1b
production have produced equivocal results.
75 Other aspects
of the IL-1 system have seldom been investigated, however,
one study did report a decrease in the ratio of serum IL-1
receptor antagonist to IL-1b in NMMD compared with MMD,
which normalized in clinical remission.
72
Study of the cytokines IL-6 and TNF-a have also pro-







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Biology of depression-heart disease comorbidity
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4
Translational PsychiatrydifferencebetweenMMD and NMMDwas reported inserum;
74
however, a study of ex-vivo mitogen-stimulated peripheral
blood mononuclear cells did demonstrate an increase in IL-6
production in MMD relative to both NMMD and controls.
21
There is also poor evidence of increased serum TNF-a inMMD
relative to NMMD as reported by one study,
73 yet others have
found no signiﬁcant difference in serum.
71
In addition further aspects of the inﬂammatory response
have also been investigated in MMD, including the acute
phase proteins: CRP, haptoglobin and transferrin, and a-2-
macroglobulin. Of these factors, CRP has been found to be
elevatedinNMMDrelativetoMMDandcontrols,whereasa-2-
macroglobulin was higher in MMD relative to NMMD and
controls.
75 Haptoglobin and transferrin were found to be
higher in both MMD and NMMD relative to controls but did not
signiﬁcantly vary between depressive groups.
21 In contrast
with these results, others have reported that serum haptoglo-
bin was signiﬁcantly higher in patients with MMD than
NMMD,
76 or else not different between MMD, NMMD or
controls.
75 Taken together, these consistently contradictory
results in both pro-inﬂammatory cytokines and acute phase
proteinssuggestthattheinﬂammatorysystemisunlikelytobe
differentially disordered in MMD as compared with NMMD.
Several authors have compared indices of adaptive
immunity in MMD and NMMD. One study suggests an
impairment of Th1-mediated immunity in MMD as these
patients demonstrated reduced mitogen-stimulated whole
blood IL-2 and interferon gamma (IFN-g) production relative
to both NMMD and controls at the untreated baseline.
24 Other
studies, however, have demonstrated an increase in the Th1
marker neopterin in serum relative to NMMD,
73 and no
signiﬁcant difference in constitutive serum levels of the Th1
cytokine IFN-g.
74 A contrasting result has also been reported
for IL-2 where MMD had greater ex-vivo peripheral blood
mononuclear cell mitogen-stimulated production of IL-2
relative to NMMD and controls.
77 This discrepancy from the
earlier result may be explained by the reduction in absolute
lymphocyte numbers observed in MMD patients in that
study—thereby confounding the result in whole blood.
24 In
contrast to the Th1 cytokines no signiﬁcant differences have
been reported in the Th2 cytokines IL-4 and IL-10.
24,71,77
Alterations in cell population numbers have also been
observed in MMD relative to NMMD. One group noted an
increase in the absolute CD4þ cell count in addition to an
increased CD4þ:CD8þ ratio that was not altered in clinical
remission. This was not accompanied by any changes in
absolute CD8þ cell count or other T-cell populations when
comparing MMD and NMMD patients although natural killer
cell activity was reduced in NMMD patients and signiﬁcantly
negatively correlated with depression severity.
77 Another
group reported an increased absolute monocyte count in
NMMD relative to both MMD and controls,
75 and the same
group found no signiﬁcant difference in absolute natural killer
cell count between MMD and NMMD although the depressed
groups were signiﬁcantly higher than controls.
24
HPA axis dysfunction has also been assessed as a
potential differential biological marker for MMD. Several






↓ GR sensitivity HPA axis dysregulation





↑ COX, Kinin, Complement cascade activation ↑ Heart rate Vasoconstriction
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Dyslipidaemia Macrophage, T cell infiltration and activation
↑ Sympathetic tone
Figure 2 Biological mechanisms for the bidirectional relationship between depression and CVD.
Biology of depression-heart disease comorbidity
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Biology of depression-heart disease comorbidity
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7
Translational Psychiatrysuppression test as a potential discriminator between MMD
and NMMD were included in a meta-analysis by Nelson and
Davis,
78 which found that there was no signiﬁcant difference
in rates of DEX suppression test non-suppression between
MMD and NMMD after adjustment for inpatient/outpatient
status. Other measures of HPA axis function such as serum
adrenocorticotrophic hormone (ACTH) or cortisol have
occasionally been reported in elevated levels in MMD as
compared with NMMD,
72 however, the majority of studies
report no signiﬁcant difference.
21,24,74
It is also of particular relevance to note that a small
study found no signiﬁcant difference between MMD, NMMD,
‘minor depression’ or controls in regards to several indices
of coagulation; prothrombin time, activated partial thrombo-
plastin time and platelet aggregation to collagen or adenosine
diphosphate.
79
Atypical depression. Relatively few studies have assessed
differentially disordered biomarkers in atypical depression. A
study of whole blood lipopolysaccharide stimulated cytokine
production found that patients with atypical depression
expressed more IL-2 and less IL-4 resulting in an overall
increased IL-2:IL-4 ratio as compared with typical
depression. The same study found no signiﬁcant difference
for TNF-a or IL-6.
80 Such a report would suggest a Th1 shift
in the basal immune state associated with atypical
depression relative to typical depression. Another study of
mitogen-stimulated peripheral blood mononuclear cells found
no signiﬁcant difference in IL-1b or IL-2 production between
the atypical and typical depressive subtypes.
81 A single
report has also identiﬁed increased serum leptin as a marker
of atypical depression, which was signiﬁcantly different from
both typical depression and controls.
82 The signiﬁcance of
this result is unclear as it awaits replication.
Some evidence also suggests differentially disordered cell
populations in typical compared with atypical depression.
Although there appears to be no signiﬁcant difference in
lymphocyte cell counts,
83 one study found that lymphocyte
proliferative response to mitogens differed slightly between
the subtypes; typical MD showed an attenuated proliferative
response to both concavalin A and low-dose phytohemagglu-
tanin whereas atypical MD showed an attenuated response to
phytohemagglutanin only.
84 The (patho-) physiological sig-
niﬁcance of this result is questionable. A single report also
found natural killer cell counts to be signiﬁcantly higher in
typical MD than atypical MD, which was in turn signiﬁcantly
higher than controls.
83 Indices of HPA axis dysfunction also
do not appear to be differentially disordered between atypical
and typical depression
81 (Table 2a).
Dysthymia. The evidence for a differential biological proﬁle
in dysthymia is again inconsistent. Much of this investigation
has focused on the pro-inﬂammatory cytokine IL-1b. One
group investigated IL-1b in individuals with dysthymia and
MD, and distinguished between typical and atypical features
for both of these subtypes. Their results suggested that
individuals with dysthymia, irrespective of whether typical or
atypical features were present, had signiﬁcantly elevated
levels of IL-1b relative to controls. Although typical and
atypical dysthymics had higher levels of IL-1b relative to
typical and atypical major depressives, the authors did not
report if these differences reached statistical signiﬁcance.
Additionally, concentrations of IL-1b increased with
phytohemagglutinin dosage among all depressive subtypes
but not for controls. Taken together, this study would seem to
suggest that dysthymia, but not MD, is characterized by
overexpression of IL-1b. Moreover, this overexpression was
signiﬁcantly and positively associated with baseline severity
scores and duration of illness.
81
More recent studies have also suggested that dysthymia
may be characterized by higher overexpression of IL-1b than
MD. In a study by Schlatter et al. the dysthymic group had
signiﬁcantly higher levels of IL-1b relative to controls, and
B30% higher levels of IL-1b production relative to those with
MD, however, this latter difference again did not reach
signiﬁcance. They also reported the absence of any associa-
tions between IL-1b and clinical characteristics of dysthymia
such as severity or duration of illness.
25,26 Furthermore, they
did not ﬁnd signiﬁcant differences in TNF-a expression
between any of the depressive subtypes or between
dichotomized depression and controls.
25
These ﬁndings are somewhat complicated by those
reported by Maes et al.
20 In their study, Maes et al. found
that MD patients had signiﬁcantly higher IL-1b levels relative
to controls, whereas intermediate levels of IL-1b were evident
among patients with minor depression (dysthymia, adjust-
ment disorder with depressed mood). However, as with the
aforementioned studies, the differences in IL-1b levels
between MD and dysthymia for IL-1b levels was not actually
signiﬁcant. However, comparison of these ﬁndings is difﬁcult
as in Maes et al. dysthymia and adjustment disorder with
depressed mood were combined into the category of ‘minor
depression’, and information regarding the duration of
depressive symptoms among dysthymic and MD patients
was not reported.
20
These same studies suggest that MD and dysthymia do not
differ signiﬁcantly in the level of overexpression of IL-6.
21,25,26
A more recent study also found no signiﬁcant difference
between MD and dysthymia in plasma IL-6 or serum brain-
derived neurotrophic factor.
85
A recent genotypic analysis of patients with post-stroke
depression determined that several polymorphisms were
differentially associated with major and minor post-stroke
depression. The IL-4þ33C/C genotype was associated with
post-stroke MD only, whereas the IL-10-1082A/A genotype
was found to be associated with both post-stroke MD and
minor depression.
86
In addition to these investigations of cytokines, a series of
studies by Thomas et al. detail the lack any signiﬁcant
differences between MD, controls and ‘subsyndromal depres-
sion’ in serum levels of IL-1b, CRP, intercellular adhesion
molecule-1 or vascular cell adhesion molecule-1.
87,88
Evidence of HPA axis dysfunction in dysthymia is also
somewhatinconsistent.Onegroupinvestigatedcortisollevels
in samples of patients with MD and minor depression, they
found that with DEX and basal cortisol levels as covariates,
MD patients had signiﬁcantly higher post-DEX cortisol levels
relative to controls, whereas patients with minor depression
had intermediate levels.
20 However, an earlier study by the
same group found no signiﬁcant difference between any
Biology of depression-heart disease comorbidity
BT Baune et al
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to be higher in the atypical/typical subtypes of MD than the
atypical/typical subtypes of dysthymia. The same study did
not ﬁnd any difference between MD and dysthymia in
lymphocyte populations.
83 No signiﬁcant differences between
MD and dysthymia were detected on mitogen-induced
lymphocyte proliferation assays.
84
A study investigating the indices of clotting prothrombin
time, activated partial thromboplastin time and platelet
aggregation to collagen or adenosine diphosphate found no
signiﬁcant difference between patients with minor depression
and MD, or between depression groups and controls
79
(Table 2b).
Psychotic depression. In biomarker studies of the
psychotic subtype of depression most attention has
concentrated on differential dysregulation of the HPA axis.
Meta-analysis of DEX suppression test studies suggests that
patients with psychotic depression were signiﬁcantly more
likely to be non-suppressors in response to DEX (odds ratio:
3.0, 95% conﬁdence interval, 2.2–4.1),
78 however, DEX
suppression test studies published since have continued to
report inconsistent results.
89,90 Other indices of HPA axis
functioning have also been shown to discriminate between
psychotic and non-psychotic MD. Intensive monitoring of
serum cortisol levels suggests that patients with psychotic MD
may have a higher mean serum cortisol,
91 a higher cortisol
nadir and higher evening cortisol relative to both patients with
non-psychotic MD and controls.
92,93 However, others have
found that the mean serum cortisol and 24h cortisol amplitude
did not differ between psychotic and non-psychotic MD.
89,94
Similarly, opposing results for 24h ACTH levels have also
been reported.
91,94 Examination of other hormones in the
hypothalamus–pituitary axis have also shown no signiﬁcant
differences between psychotic and non-psychotic MD in
assays of thyroid-stimulating hormone response to
thyrotrophin-releasing hormone or growth hormone response
to growth hormone releasing factor.
90 These results may be
tentatively interpreted to suggest there may be some degree
of differential dysregulation in the HPA axis related to the
psychotic/non-psychotic distinction within MD.
Other differential mechanisms potentially relevant to CVD
have been reported. One study suggests that platelet
serotonin was increased in samples from patients with
psychotic MD as compared with non-psychotic MD.
89 Also,
plasma dopamine b-hydroxylase (the enzyme converting
dopamine to norepinephrine) activity has been reported to
be lower in patients with psychotic relative to non-psychotic
MD
95 (Table 2c).
BDs. Several studies in patients with BD observed an
activation of the immune system during the manic, the
depressed or the euthymic states of bipolar illness. Some
authors suggested that certain markers may be speciﬁc to
each state, however, no consistent pattern has emerged as of
yet. Several pro-inﬂammatory cytokines have been
investigated in BD. Investigating the ex-vivo mitogen-
stimulated cytokine production of peripheral blood
mononuclear cells from manic patients with BD, a reduced
production of IFN-g was observed that persisted in both acute
mania and remission.
96 These ﬁndings were replicated by
others, who also observed an increase in plasma levels of
IL-1 receptor antagonist, sCD4 and sCD8 in mania.
97 In
contrast, Kim et al.
98 were unable to replicate the ﬁnding of
increased IFN-g in a cohort of medication free manic patients,
however, they did note an increase in the IFN-g/IL-4 ratio
which is purported to be a more valid measure of the pro-
inﬂammatory activities of IFN-g than IFN-g levels alone.
Other pro-inﬂammatory cytokines have also been found to
be elevated in bipolar mania. Several authors have demon-
strated an elevation of TNF-a levels,
99,100 and two studies
demonstrated an increase in soluble TNF receptor 1 although
they failed to replicate the ﬁnding of increased TNF-a.
101,102
Similarly, several authors have documented increased IL-6
during a manic phase of bipolar illness.
98,99,103 Elevations in
pro-inﬂammatorycytokinesarenotrestrictedtothemanicstate
as TNF-a was increased in both manic and depressed
patients,
99 a ﬁnding also reported for IL-6.
103 Other authors
have demonstrated elevations in the production of pro-
inﬂammatory cytokines and CRP as a trait marker of BD,
independent of the current psychopathological state.
104–106
Earlier studies had also demonstrated raised levels of serum
sIL-2R among rapid cycling
107 and manic
108 bipolar patients
with normalization in remission.
107–109 In contrast, some
studies found no signiﬁcant association between pro-inﬂam-
matory cytokines and BD regardless of current state.
102,110–112
A dysregulation of the production of anti-inﬂammatory
cytokines IL-4 and IL-10 has also been implicated in BD. For
example, it was reported that IL-10 is increased in patients
with BD irrespective of the current psychopathological
state.
100,106,112 However, studies in cohorts of exclusively
manic
96,97 or euthymic
113 patients found no signiﬁcant
association with IL-10 levels.
99,111 In support of an increase
in anti-inﬂammatory cytokines in BD, elevated levels of the
anti-inﬂammatory cytokine IL-4 were repeatedly reported in
both the manic and euthymic states of bipolar illness.
98,103,113
In contrast, an ex-vivo examination of IL-4 could not ﬁnd an
association with mania.
97
Beyond the investigation of inﬂammatory proteins as
markers of diagnostic subtypes of BD, these immunological
factors appear to be positively correlated with the severity of
bipolar symptoms. Although some reported that serum CRP
was associated with scores of the Young Mania Rating Scale
score, but not Hamilton Depression scale score,
114 others
found that a Young Mania Rating Scale score was positively
correlated with IL-2 and IL-6, and the Hamilton Depression
scale with IL-6 only.
103 These ﬁndings are not uncontested,
however, as several other studies found no association
between several of these markers (CRP, IL-6, IL-8, TNF-a,
IL-12 and IL-10) and symptom severity in BD.
99,110,115
Beyondtheinnateimmunemarkersdiscussedabove,arecent
study has demonstrated derangement of indices of adaptive
immunity including T-cell subtypes and cytokines.
111 An emer-
ging body of literature proposes that disruptions of T-cell
mediated immunity may interact with the aforementioned
mechanismsofinﬂammatorymarkersandHPAaxistocontribute
to the progression of neuropsychiatric disorders.
116,117
Biology of depression-heart disease comorbidity
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Translational PsychiatryA key complication of studies in bipolar patients is the
purported immune effects of lithium and other mood stabi-
lizers. Several studies have demonstrated differences in
immune parameters between lithium-treated patients and un-
medicated patients,
104,113,118 however, this effect is not
always replicated.
101,102,109,114 Any immune-modulatory
effect appears to be related to chronic treatment with this
agent and could not be replicated by in-vitro addition of lithium
to samples from un-medicated patients.
104 Additionally, it was
suggested that the progressive nature of BD may act as a
confounder as the early and late stages of the illness showed
a differential proﬁle of TNF-a, IL-6 and IL-10 expression.
106
Several studies have reported dysfunction of the HPA
axis in patients with BD. Similarly to unipolar depression,
BD patients frequently demonstrate non-suppression of the
cortisol response to DEX and/or corticotrophin releasing
hormone in manic,
119,120 mixed
120 and depressed states.
121
It is notable, however, that the largest study of HPA axis
functionality in BD did not ﬁnd any signiﬁcant difference in
post-DEX cortisol between BD patients and controls.
122
Overall, the study results remain inconclusive as both, a
normalization
119,121 and a continued elevation
123,124 of post-
DEX cortisol suppression was found in remitted BD patients.
BD has also been associated with increased basal cortisol
levels
119,122,124 and a greater cortisol awakening response
and increased diurnal cortisol slope.
122 In remission, though,
basal cortisol secretion was not signiﬁcantly different from
controls, suggesting that this ﬁnding may be a marker of
illness activity.
125
It is also relevant to note that one study has demonstrated
increased levels of serum von-Willebrand factor in patients
with BD when compared with controls
102 (Tables 2d and 3).
Vascular depression. Vascular depression is associated
with vascular disease, risk factors (e.g., diabetes mellitus,
obesity) and late onset or change in the course of early-onset
depression following the onset of vascular disease.
126 The
‘vascular depression’ hypothesis proposed by Alexopoulos
et al.
126 suggests that characteristics of cerebrovascular
disease and their risk factors are involved in the
development of late-life depression. This hypothesis is based
on the observed high comorbidity between depression and
CVDs as well as risk factors such as hypertension, diabetes,
coronary artery disease, stroke and the high rate of silent
stroke and white matter hyperintensities among elderly
individuals with depression.
126–128 A study by Krishnan
et al.
129 reported that the crude and adjusted risks for
vascular depression were associated with age and late-onset
depression. Clinical features in patients with vascular
depression are characterized by signiﬁcant loss of interests
(apathy), cognitive dysfunction and psychomotor retar-
dation.
130 The degree of cognitive dysfunction observed in
patients with vascular depression is usually greater than in
patients with non-vascular depression.
131 Causative factors of
depression in the elderly are not well understood, though a role
of biological risk factors, such as decreased arterial elasticity
contributing to this late-life depression has been discussed.
132
Decreased arterial elasticity, which is an important biologi-
cal marker of atherosclerosis, has been observed in
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Translational Psychiatryartery’s structural and functional properties, that is, the
artery’s ability to stretch when under stress.
133,134 Increased
arterial stiffness (decreased arterial elasticity) is associated
with cerebrovascular disease and death independent of
atherosclerosis and other factors
133,135–137 as well as with
depression in the elderly.
135 The strongest associations were
seen among those who met the criteria for a DSM-IV
depressive disorder (major or minor depression, or dysthy-
mia) compared with those who reached a clinical level of
depressive symptoms (CES-D score X16) but did not meet
the criteria for a depressive disorder. Those with a depressive
disorder tended to have an increased risk for an abnormal
distensibility coefﬁcient of the common carotid artery and for
anabnormalpulsewave velocitymeasurements,twomarkers
of structural and functional vessel wall properties.
138–140
Further studies support the hypothesis of arterial stiffness in
depression.
141 Arterial elasticity was examined in a sample of
females with a lifetime DSM-IV-TR diagnosis of MD, currently
depressed (onset p30 days) with very severe depressive
symptoms (HDRS-17 score X24). Depressed patients had
signiﬁcantly higher baseline pulse wave velocity values
relative to controls. Patients’ pulse wave velocity and HDRS
scores signiﬁcantly decreased following a 6-week antidepres-
sant treatment period. Signiﬁcantly greater vascular improve-
ments were seen among full responders to treatment (HDRS
scores reduced by X50%) as compared with partial respon-
ders indicating that patients’ degree of improvement in arterial
stiffness was related to the degree of reduction of depressive
symptoms. Interestingly, clinical features such as illness
duration, number of previous episodes, melancholic or
psychotic features or electroconvulsive therapy did not alter
the results. Taken together, these results suggest that
clinically acute MDE may have a short-term effect on the
vascular wall, which results in increased arterial stiffness
possibly explaining some of the associations observed
between CVD and depression.
141
Summary
The association between CVDs and depression using the
latter as a single diagnostic entity is well established and
suggested to be bidirectional.
5 With regard to subtypes of
depression the association is less clear, but seems to vary in
itsstrengthbysubtype.Also,reviewsinvestigatingifbiological
mechanisms implicated in the association between CVD and
depression deﬁned as a single entity would also apply to the
various subtypes of depression are lacking. Thus, the aim of
this review was to determine if a differential involvement of
biological mechanisms for subtypes of depression is evident
inthepublishedliteratureandifso,ifthiscontributestoexplain
differences in the strength of the association between CVD
and depression subtypes.
This review suggests a dose-response relationship be-
tween the increasing severity of depressive symptoms and
immune activation as well as HPA axis hyperactivity. It also
found evidence that these two mechanisms are differently
involved in the relationship with CVD depending upon
depression subtype.
20,21,24,25,72,81,88,89,142,143 However, the
identiﬁcation of a subtype-speciﬁc functional pattern for both
mechanisms is not possible at this stage as study results are
inconsistent. Other mechanisms such as arterial stiffness or
endothelial dysfunction, which also are involved in the
relationship between the disease entity depression and CVDs
havenotbeeninvestigatedinsubtypesofdepression,withthe
notable exemption of BD.
66 The inconsistent study results are
likely to be explained by the respective studies’ limitations in
termsofdesignfactorsandinconsistentmethodologies.Many
of the studies investigating biological mechanisms used
samples that were small in number and heterogeneous in
clinical and demographic participant characteristics such as
severity of symptoms, duration of illness, number of comor-
bidities and histories of pharmacological and psychological
therapies. They also varied signiﬁcantly in the instruments
and criteria used to classify depression, and techniques
utilized in the measurement of biological markers. Another
problem in the comparison of results is the variation in the
delay between occurrence of CVD and assessment of
depression and the heterogeneity in severity of CVDs. The
paucity of longitudinal studies with a repeated assessment of
both disease status is another limitation of reported studies.
On the other hand, and despite some overlap, the group of
‘CVDs’ is also heterogeneous with different clinical character-
istics, risk factors and prognoses. The vast majority of studies
examined myocardial infarction as an endpoint within the
group of CVDs when studying the association with depres-
sion, and the number of studies reporting on other cardiovas-
cular endpoints is considerably smaller. At least two of the
biological mechanisms described above, arterial stiffness and
endothelial dysfunction, are established steps in the patho-
physiological cascade of disease development and could be
considered endpoints in themselves. Thus, for a better
understanding of a causal relationship it is not only necessary
to differentiate between subtypes of depression but also
between cardiovascular endpoints. An alternative approach
for the latter is the analysis of the relationships of subtypes of
depression with subclinical disease, for example, intima-
media-thickness or vascular brain lesions such as white
matter lesions and lacunar infarcts, or, to study the associa-
tion between subtypes of depression and speciﬁc biological
mechanisms directly. The latter is possible for some of the
discussed mechanisms, for example, arterial stiffness,
endothelial dysfunction and to some extent the activation of
the immune system and dysfunction of the HPA axis. These
analyses, however, have to be prospective in design with
repeated assessmentsof the clinical disease statusas well as
the subclinical or biological surrogates. The differences in the
strength of associations between speciﬁc subtypes of
depression and CVDs, as reported in the literature, suggests
that different biological mechanisms might be involved in
mediating these associations. This assumption would enable
researchers to describe distinct (patho-) physiological proﬁles
for subtypes of depression.
The implications for psychological treatment in reducing
CVD mortality have also been raised. It has been suggested
that if depression does indeed cause an increase in CVD
mortality,thenonewouldexpecttoseeareductioninmortality
following psychological intervention. However, recent studies
have not conﬁrmed this expectation.
144,145 Additionally,
although depression may be a factor that predisposes a
patient to the development of CVD, it may not necessarily be
Biology of depression-heart disease comorbidity
BT Baune et al
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Translational Psychiatrythe factor that maintains the development of CVD. Systemic
immune activation may be stimulated by one depressive
episode and ongoing regardless of the episode going into
remission through treatment. Very little research has inves-
tigatedinﬂammation anddepression longitudinally. Moreover,
adifferentconceptmayberequired forelderlypatientsamong
whom vascular depression is commonly seen.
A concept that applies a differential model of CVD and
depressivesubtypesmaybemoreappropriatecomparedwith
a unifying model of depression used in the past. Research
moving beyond the unifying model and assessing both single
CVDs and depressive subtypes longitudinally may enhance
efforts to unravel causes and mechanisms of the bidirectional
relationship between CVD and depression. Such research
would potentially lead to the development of timely and
appropriate measures for detection, prevention and treatment
for CVD and depression.
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